Latest Tax Rebates News

X2M Connect accelerated revenue growth in Q3 FY26 with a 67% increase, driven by strong demand in South Korea and new Australian smart community deals. The company’s capital raise and expanding customer base underpin its push into new markets despite ongoing cash burn.

Greenvale Energy has sharpened its uranium exploration focus with new step-out targets at Oasis and secured a critical exploration licence at Douglas River, while pushing its Alpha Project into product development.

Noxopharm signed a strategic MoU with Tezcat Biosciences, published major Sofra RNA research, and appointed Dr Olivier Laczka as CEO, while reporting positive safety data from its HERACLES trial and improving cash flow.

Wide Open Agriculture appoints Craig Swan as CEO and pivots to a contract manufacturing model to improve economics and scale lupin protein production, while receiving a A$1.69 million R&D tax rebate.

Nyrada has secured ethics approval to start its Phase IIa trial of Xolatryp in heart attack patients, with recruitment beginning in April 2026. The biotech also bolsters its cash position to AU$6.74 million and pursues new oncology indications.

Wide Open Agriculture Ltd (ASX: WOA) has received a A$1,686,579 R&D tax rebate for the 2024-25 financial year, reflecting its significant innovation efforts in lupin protein development across Australia and Germany. The rebate will support the company’s commercialisation and growth initiatives.

PlaySide Studios Limited (ASX: PLY) has announced that its upcoming game MOUSE: P.I. For Hire has exceeded 1.5 million wishlists, surpassing previous guidance, ahead of its global digital launch on 16 April 2026. The company expects FY26 revenue to exceed FY25 with reduced operating costs.

Sparc Technologies has secured a $680,000 non-dilutive advance on its anticipated FY26 R&D tax refund, strengthening its cash flow as it accelerates commercialisation of its graphene additive ecosparc and green hydrogen ventures.

Argenica Therapeutics has secured a nearly $4 million R&D tax incentive rebate for FY25, strengthening its cash position as it prepares for a pivotal Phase 2b trial of its neuroprotective peptide ARG-007.

New Frontier Minerals has secured technical approval for its Mining Lease Application at the Big One Copper Deposit, setting the stage for potential near-term copper production amid a tightening global copper market.

EMVision Medical Devices has secured a $3.8 million R&D tax rebate and gained approval to claim rebates on overseas expenditures, strengthening its financial footing as it advances clinical trials for its neurodiagnostic device.

South Harz Potash Limited has raised A$1.25 million to fund exploration at its newly licensed copper-gold projects in Sweden, signalling a strategic pivot towards critical minerals and a planned rebrand to Turnstone Resources.